Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Novartis receives Complete Response letter from the US Food and Drug Administration for its investigational vaccine Menveo
Novartis, 07/01/09
Novartis Vaccines and Diagnostics received feedback from the US Food and Drug Administration in the form of an initial regulatory determination on the Biologics License Application for the investigational vaccine Menveo.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Article Search
Sponsor


See Latest Articles


